scholarly journals Nasobiliary drainage induces long-lasting remission in benign recurrent intrahepatic cholestasis

Hepatology ◽  
2005 ◽  
Vol 43 (1) ◽  
pp. 51-53 ◽  
Author(s):  
Janneke M. Stapelbroek ◽  
Karel J. van Erpecum ◽  
Leo W. J. Klomp ◽  
Niels G. Venneman ◽  
Thijs P. Schwartz ◽  
...  
Keyword(s):  
Intrahepatic Cholestasis ◽  
Benign Recurrent Intrahepatic Cholestasis ◽  
Nasobiliary Drainage

NASOBILIARY DRAINAGE INDUCES REMISSION IN BENIGN RECURRENT INTRAHEPATIC CHOLESTASIS

2005 ◽  
Vol 40 (5) ◽  
pp. 628
Author(s):  
JM Stapelbroek ◽  
KJ Van Erpecum ◽  
LWJ Klomp ◽  
MP Schwartz ◽  
AS Knisely ◽  
...  
Keyword(s):  
Intrahepatic Cholestasis ◽  
Benign Recurrent Intrahepatic Cholestasis ◽  
Nasobiliary Drainage

scholarly journals Nasobiliary Drainage for Benign Recurrent Intrahepatic Cholestasis in Patients Refractory to Standard Therapy

2016 ◽  
Vol 39 (6) ◽  
pp. 164 ◽  
Author(s):  
Tolga Yakar ◽  
Mehmet Demir ◽  
Huseyin S Gokturk ◽  
Ayse G Unler Kanat ◽  
Alper Parlakgumus ◽  
...  
Keyword(s):  
Intrahepatic Cholestasis ◽  
Gamma Glutamyl Transpeptidase ◽  
Duration Of Treatment ◽  
Endoscopic Retrograde ◽  
Safety And Efficacy ◽  
Benign Recurrent Intrahepatic Cholestasis ◽  
Episode Duration ◽  
Nasobiliary Drainage ◽  
Glutamyl Transpeptidase ◽  
Group Post

Purpose: Benign recurrent intrahepatic cholestasis (BRIC) is characterized by episodic cholestasis and pruritus without anatomical obstruction. The aim of this study was to evaluate the safety and efficacy of nasobiliary drainage (NBD) in patients with BRIC refractory to medical therapy and to determine whether the use of NBD prolongs the episode duration. Methods: This was a multicenter retrospective study consisting of 33 patients suffering from BRIC. All patients were administrated medical treatment and 16 patients who were refractory to standard medical therapies improved on treatment with temporary endoscopic NBD. Duration of treatment response and associated complications were analyzed. Results: Sixteen patients (43% females) underwent 25 NBD procedures. The median duration of NBD was 17 days. There were significant improvements in total and direct bilirubin and alanine aminotransferase, aspartate aminotransferase, alkaline phosphatase and gamma-glutamyl transpeptidase on the 3rd day of NBD. Longer clinical remission was monitored in the NBD group. Post-endoscopic retrograde cholangiopancreatography pancreatitis was observed in one of 16 cases. Conclusion: NBD effectively eliminates BRIC in all patients and improves biomarkers of cholestasis. It can be suggested that patients with attacks of BRIC can be treated with temporary endoscopic NBD; however, the results of this study should be confirmed by prospective studies in the future.

Benign Recurrent Intrahepatic Cholestasis

1963 ◽  
Vol 268 (13) ◽  
pp. 708-711 ◽  
Author(s):  
Robert H. Schapiro ◽  
Kurt J. Isselbacher
Keyword(s):  
Intrahepatic Cholestasis ◽  
Benign Recurrent Intrahepatic Cholestasis

scholarly journals Benign recurrent intrahepatic cholestasis--25 years of follow-up.

1987 ◽  
Vol 63 (738) ◽  
pp. 295-296 ◽  
Author(s):  
C. Putterman ◽  
S. Keidar ◽  
J. G. Brook
Keyword(s):  
Intrahepatic Cholestasis ◽  
Benign Recurrent Intrahepatic Cholestasis

Benign recurrent intrahepatic cholestasis. A clinico-pathologic study

1990 ◽  
Vol 20 (1) ◽  
Author(s):  
Piero Lovisetto ◽  
Paolo Raviolo ◽  
Mario Rizzetto ◽  
Luciano Marchi ◽  
Giovanni Clemente Actis ◽  
...  
Keyword(s):  
Intrahepatic Cholestasis ◽  
Pathologic Study ◽  
Benign Recurrent Intrahepatic Cholestasis

PROGRESSIVE FAMILY INTRAHEPATIC CHOLESTASIS: DIAGNOSTICS, TREATMENT (CLINICAL OBSERVATION)

2021 ◽  
Vol 19 (4) ◽  
pp. 462-467
Author(s):  
A. R. Obuhovich ◽  
◽  
N. N. Iaskevich ◽  
Keyword(s):  
Case Report ◽  
Intrahepatic Cholestasis ◽  
Clinical Observation ◽  
Gene Mutations ◽  
Literature Analysis ◽  
Genetic Progress ◽  
Benign Recurrent Intrahepatic Cholestasis

Jaundice is a manifestation of many diseases both benign and malignant. Genetic progress allowed to distinguish the group of unknown earlier rare cholestatic jaundices, which are resulted from gene mutations. There are no described algorithms of their diagnosis or treatment. In this article case report of the patient with benign recurrent intrahepatic cholestasis type 1 is presented. There is also literature analysis of this theme.

Sign in / Sign up

Export Citation Format

Share Document